Cargando…
Correlation of (18)F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
AIMS: A proportion of patients with pancreatic cancer never develop metastatic disease. We evaluated a role for (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in identifying a subset of patients with locally advanced pancreatic cancer (LAPC) who never develop metastatic disease and...
Autores principales: | Wilson, J.M., Mukherjee, S., Brunner, T.B., Partridge, M., Hawkins, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429392/ https://www.ncbi.nlm.nih.gov/pubmed/28190636 http://dx.doi.org/10.1016/j.clon.2017.01.038 |
Ejemplares similares
-
18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
por: Zhu, Wenyao, et al.
Publicado: (2018) -
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020) -
Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009) -
Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020) -
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart
por: Kong, Eunjung
Publicado: (2020)